SENSEX
NIFTY
GOLD
USD/INR

Weather

image 34    C

Global Business News

The Economic Times

Global Business / The Economic Times

details

Eli Lilly to buy Ajax Therapeutics for up to $2.3 billion

Eli Lilly is set to acquire Ajax Therapeutics for a substantial sum. This move aims to develop a new oral treatment for myelofibrosis, a rare blood cancer. Clinical data is anticipated in 2026. Lilly plans to quickly move the treatment into larger trials. The company seeks to offer another vital medicine to patients and doctors specializing in blood cancers.

27 Apr 2026 4:41 pm